Adult, stem cells continue to show remarkable results in treating injuries and diseases.
Bone Repair Cells (BRCs) were used to repair the faces of patients suffering from severe craniofacial defects.
Dr. Jose Mendonca, Director of the Head and Neck Surgery Unit of Hospital POLUSA in Lugo, Spain and previously a Clinical and Research Fellow in Oral and Maxillofacial Surgery at the UCLA School of Dentistry, go through the results of treatment with BRCs in three patients who are suffering with craniofacial defects, as follows:
The first patient was treated for severe mandibular osteoradionecrosis, or osteonecrosis of the jaw caused by radiation, and presented with pathological fracture and complete numbness of the lower lip. At 12 months post-BRC treatment, the patient displayed restored vascular function, new bone formation, fracture consolidation and total recovery of lip numbness.
The second patient was treated for post-traumatic mandibular osteomyelitis and presented with massive bone loss, chronic infection, chronic pain and total impairment of function of both mandibular nerves. At 12 months post-BRC treatment, the patient experienced complete functional nerve recovery and the formation of new bone.
The third patient was treated for iatrogenic massive bone loss in the posterior maxilla and presented with severe oral function impairment. At 12 months post-BRC treatment, the patient had new bone formation in atrophic areas.
All of the patients had a minor surgery to insert a dental implant into the newly regenerated jaw bone. Eight weeks later, the dental prosthesis (teeth) was attached to the implant completing the treatment objectives with the restoration of oral function.
“The outcome of these treatments with BRCs has been very satisfactory and acceptable. The experts observed early bone formation in the afflicted areas that eventually resulted in complete healing,” said Dr. Mendonca. “Unexpected therapeutic results from treatment with BRCs include peripheral nerve regeneration or repair, new skin formation and proliferation in blood vessels in ischemic areas!!
RSCI knew that this “trial” would succeed, but how well it came out surprised for all of us, those who have seen five years of Repair Stem Cell successes month after month. We look for unexpected side effects—always positive—ever since TheraVitae’s pioneer heart stem cells surprised everyone by improving the patients’ diabetes in one out of six cases. These “side effects” are, well, astonishing.
These sorts of results and methods are definitely going to serve the humanity in a best way.